Solve-Funded Phase 2 Observational Study Yields More Support for Repurposing Rapamycin to Reduce a Broad Range of ME/CFS Symptoms
Dr. Avik Roy is the chief scientific officer at the Simmaron Research Institute, a nonprofit organization that conducts research and observational studies on ME/CFS to find treatments for people with […]
From Solve Seed Funding to $3M NIH Grant for ME/CFS Research
Solve Ramsay Research Grant winner Dr. Lubov Nathanson and her team at Nova Southeastern University have been awarded a $3 million grant from the National Institutes of Health (NIH) to lead a […]
New Catalyst Awards to Accelerate ME/CFS and Long Covid Breakthroughs
Solve M.E. is proud to support two pioneering studies through our latest round of ME/CFS Catalyst Awards, a focused initiative to support promising research projects that have already made significant […]
Immune-Gene Variants That Help Fight Certain Infections May Also Trigger Chronic Illness
Manuel Ruiz Pablos, at the Complutense University of Madrid, and Dr. Bruno Paiva, at the University of Navarra, were awarded a Solve Ramsay Grant in 2019 to study class II […]
Solve CEO Emily Taylor Reflects On What We Built Together In 2025 and Why It Mattered
Dear Friends, As this year comes to a close, I find myself thinking not just about what we accomplished — but why it mattered. As a caregiver who understands how […]
Celiac Plexus Blocks Improve Long Covid–Associated Gastrointestinal Symptoms
Dr. Deborah Duricka is a professor at the University of Alaska; researcher at Neuroversion; and 2022 Solve Ramsay Grant Program awardee. In a new case report, Dr. Duricka described how […]
New Study Examines ME/CFS Subgroups Based on Cerebrospinal Fluid and Blood-Plasma Proteins
Dr. Akiko Iwasaki, Sterling Professor of Immunology at Yale University and winner of the 2025 Solve Catalyst Award, recently published a study on distinguishing groups of people with ME/CFS based […]
Solve-Funded Post-Exertional Malaise and Long Covid Study Featured in Leading Journal
Dr. Rob Wüst, a physiology professor at the Vrije de Universiteit (Amsterdam, Netherlands) and winner of a Solve Ramsay Research Grant, studies how diseases like Long Covid and ME/CFS affect […]
Solve Announces More Funding for Ramsay Awardees Dr. Geraldine Cambridge and Dr. Dana Yelin
Solve is proud to award research funds to Dr. Geraldine Cambridge and Dr. Dana Yelin, two world-class scientists who are finding new ways to treat people with Long Covid and […]
Autoantibody Treatments for ME/CFS and Long Covid: Dr. Scheibenbogen Urges Smarter, Targeted Research
Dr. Carmen Scheibenbogen is the director of the Institute for Medical Immunology at Charité Hospital (Berlin, Germany) and a world-leading expert on Long Covid and ME/CFS. She is also a […]
New Solve-Funded Study Backs Stellate Ganglion Block for Long Covid, ME/CFS
Dr. Deborah Duricka—affiliated assistant professor at the University of Alaska, researcher at Neuroversion, and Solve Ramsay Research Grant Awardee—continues to lead the way in understanding how we may treat people […]
Solve-Funded Researcher Reviews How Long Covid Changes Muscle Tissues To Increase Post-Exertional Malaise (PEM)
Dr. Rob Wüst is a professor at the Vrije de Universiteit (Amsterdam, Netherlands) who specializes in muscle-tissue metabolism and functioning, especially how diseases like Long Covid and ME/CFS damage muscle […]